Cancer Clinical Trials: Lowenthal Group

Our group is active in fostering participation of Tasmanian patients and haematologists/oncologists in national and international trials of new treatments for cancer and blood diseases. We are members of a number of national and international collaborative trials organisations and also are active in carrying out trials on behalf of pharmaceutical companies, under contract.

Parent Theme

Research Projects

Related Funding Bodies



  • Professor Ray Lowenthal (Honorary Member)

Team Members

  • Tanya Dargaville (O'Byrne)
  • Dr Katherine Marsden (Honorary Fellow)
  • Dr Louise Nicholson (Charge Nurse)

Local Collaborators

  • Dr Ian Byard
  • Sue Davoran
  • Elizabeth Hammer
  • Dr Rosie Harrup
  • Dr Anna Johnston
  • Dr Roger Kimber
  • Annette Moore
  • Lesley Oliver
  • Dr Ritam Prasad
  • Dr Scott Ragg
  • Dr Marketa Skala
  • Deirdre Tuck
  • Dr Rosemary Young

Related Publications

  • Clarke SJ, Yip S, Brown C, van Hazel GA, Ransom DT, Goldstein D, Jeffrey GM, Tebbut NC, Buck M, Lowenthal RM*, Boland A, Gebski V, Zalcberg J, Simes RJ; on behalf of the Australasian Gastro-Intestinal Trials Group. Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; randomised AGITG phase II study (DaVinci trial) and meta-analysis. European Journal of Cancer 2011; 47: 1826-1836.

* Denotes Menzies Researcher